State Street’s Heron Therapeutics HRTX Stock Holding History

State Street’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.08M	Buy	3,843,672 +65,629	+2%	+$76.1K	﹤0.01%	3162
2025 Q4	$4.91M	Buy	3,778,043 +126,540	+3%	+$156K	﹤0.01%	3002
2025 Q3	$4.6M	Buy	3,651,503 +189,237	+5%	+$300K	﹤0.01%	3023
2025 Q2	$7.17M	Buy	3,462,266 +208,362	+6%	+$425K	﹤0.01%	2784
2025 Q1	$7.16M	Buy	3,253,904 +107,711	+3%	+$209K	﹤0.01%	2725
2024 Q4	$4.81M	Sell	3,146,193 -46,243	-1%	-$75K	﹤0.01%	3000
2024 Q3	$6.35M	Sell	3,192,436 -2,088,430	-40%	-$4.99M	﹤0.01%	2845
2024 Q2	$18.5M	Buy	5,280,866 +2,839,996	+116%	+$8.73M	﹤0.01%	2205
2024 Q1	$6.76M	Sell	2,440,870 -40,975	-2%	-$103K	﹤0.01%	2797
2023 Q4	$4.22M	Buy	2,481,845 +80,283	+3%	+$88.4K	﹤0.01%	3027
2023 Q3	$2.47M	Buy	2,401,562 +70,324	+3%	+$100K	﹤0.01%	3235
2023 Q2	$2.7M	Sell	2,331,238 -224,755	-9%	-$401K	﹤0.01%	3274
2023 Q1	$3.86M	Sell	2,555,993 -30,939	-1%	-$77.5K	﹤0.01%	3086
2022 Q4	$6.47M	Sell	2,586,932 -6,251,774	-71%	-$20.1M	﹤0.01%	2921
2022 Q3	$37.3M	Sell	8,838,706 -7,490,090	-46%	-$29.3M	﹤0.01%	1803
2022 Q2	$45.6M	Buy	16,328,796 +3,405,427	+26%	+$13.7M	﹤0.01%	1709
2022 Q1	$73.9M	Buy	12,923,369 +5,230,958	+68%	+$38.3M	﹤0.01%	1504
2021 Q4	$70.2M	Buy	7,692,411 +1,200,504	+18%	+$12.3M	﹤0.01%	1566
2021 Q3	$69.4M	Buy	6,491,907 +1,779,188	+38%	+$21.7M	﹤0.01%	1567
2021 Q2	$73.1M	Buy	4,712,719 +128,420	+3%	+$2.04M	﹤0.01%	1556
2021 Q1	$74.3M	Buy	4,584,299 +602,495	+15%	+$10.7M	﹤0.01%	1458
2020 Q4	$84.3M	Sell	3,981,804 -428,430	-10%	-$7.45M	0.01%	1278
2020 Q3	$65.4M	Buy	4,410,234 +569,776	+15%	+$8.89M	﹤0.01%	1259
2020 Q2	$56.5M	Buy	3,840,458 +410,333	+12%	+$6.74M	﹤0.01%	1379
2020 Q1	$40.3M	Buy	3,430,125 +54,068	+2%	+$1.02M	﹤0.01%	1402
2019 Q4	$79.3M	Buy	3,376,057 +663,063	+24%	+$14.7M	0.01%	1200
2019 Q3	$50.2M	Sell	2,712,994 -1,349,319	-33%	-$24.8M	﹤0.01%	1435
2019 Q2	$75.5M	Buy	4,062,313 +829,686	+26%	+$16.6M	0.01%	1220
2019 Q1	$79M	Sell	3,232,627 -253,365	-7%	-$6.63M	0.01%	1170
2018 Q4	$90.4M	Buy	3,485,992 +236,508	+7%	+$6.5M	0.01%	959
2018 Q3	$103M	Sell	3,249,484 -217,402	-6%	-$8.1M	0.01%	1059
2018 Q2	$135M	Buy	3,466,886 +323,336	+10%	+$10.3M	0.01%	860
2018 Q1	$86.8M	Buy	3,143,550 +914,527	+41%	+$20.7M	0.01%	1089
2017 Q4	$40.3M	Buy	2,229,023 +308,202	+16%	+$5.03M	﹤0.01%	1572
2017 Q3	$31M	Buy	1,920,821 +183,512	+11%	+$2.88M	﹤0.01%	1708
2017 Q2	$24.1M	Sell	1,737,309 -50,369	-3%	-$730K	﹤0.01%	1853
2017 Q1	$26.8M	Buy	1,787,678 +420,113	+31%	+$5.81M	﹤0.01%	1732
2016 Q4	$17.9M	Buy	1,367,565 +270,022	+25%	+$4.24M	﹤0.01%	1981
2016 Q3	$18.9M	Buy	1,097,543 +103,311	+10%	+$1.92M	﹤0.01%	1808
2016 Q2	$17.9M	Sell	994,232 -214,340	-18%	-$4.18M	﹤0.01%	1830
2016 Q1	$22.9M	Sell	1,208,572 -215,739	-15%	-$4.26M	﹤0.01%	1631
2015 Q4	$38M	Buy	1,424,311 +326,874	+30%	+$8.74M	﹤0.01%	1309
2015 Q3	$26.8M	Sell	1,097,437 -101,140	-8%	-$3.37M	﹤0.01%	1553
2015 Q2	$37.3M	Buy	1,198,577 +900,822	+303%	+$16.9M	﹤0.01%	1439
2015 Q1	$4.33M	Buy	297,755 +68,163	+30%	+$768K	﹤0.01%	2638
2014 Q4	$2.31M	Buy	229,592 +15,227	+7%	+$124K	﹤0.01%	2979
2014 Q3	$1.78M	Buy	214,365 +29,203	+16%	+$272K	﹤0.01%	3066
2014 Q2	$2.28M	Buy	185,162 +172,762	+1,393%	+$2.06M	﹤0.01%	3003
2014 Q1	$173K	Buy	+12,400	New	+$166K	﹤0.01%	3474

Other funds holding HRTX

RCMNY

Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return

Clearline Capital New York $1.29B AUM 38.13% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return